Royal Jelly May Ease Adverse Effects of RCC Drug Therapy

Royal jelly, a substance secreted by worker honeybees that is the exclusive food for queen bees, may ease the adverse effects of tyrosine kinase inhibitor (TKI) therapy for advanced renal cell carcinoma (RCC).01/11/2019

Source: Kidney Cancer Association - January 11, 2019 Category: Urology & Nephrology Source Type: news